194 related articles for article (PubMed ID: 29282454)
1. Interventions for Nongenital Molluscum Contagiosum in Persons Without Immune Deficiency.
van der Wouden JC; Koning S; Katz KA
JAMA Dermatol; 2018 Feb; 154(2):203-204. PubMed ID: 29282454
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of molluscum contagiosum in children.
Myhre PE; Levy ML; Eichenfield LF; Kolb VB; Fielder SL; Meng TC
Pediatr Dermatol; 2008; 25(1):88-95. PubMed ID: 18304162
[TBL] [Abstract][Full Text] [Related]
3. Reviewing the use of imiquimod for molluscum contagiosum.
DiBiagio JR; Pyle T; Green JJ
Dermatol Online J; 2018 Aug; 24(6):. PubMed ID: 30142710
[TBL] [Abstract][Full Text] [Related]
4. Treatment of molluscum contagiosum with topical 5% imiquimod cream.
Skinner RB; Ray S; Talanin NY
Pediatr Dermatol; 2000; 17(5):420. PubMed ID: 11085678
[No Abstract] [Full Text] [Related]
5. An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.
Barba AR; Kapoor S; Berman B
Dermatol Online J; 2001 Feb; 7(1):20. PubMed ID: 11328641
[TBL] [Abstract][Full Text] [Related]
6. Ingenol mebutate gel for the treatment of molluscum contagiosum: An open-label comparative pilot study.
Shin K; Bae KN; Kim HS; Kim BS; Kim MB; Ko HC
J Am Acad Dermatol; 2020 Jan; 82(1):254-255. PubMed ID: 31499155
[No Abstract] [Full Text] [Related]
7. Topical imiquimod for molluscum contagiosum in T cell immunodeficiency.
Yazdani S; Stiehm ER
Pediatr Infect Dis J; 2003 Jun; 22(6):575-6. PubMed ID: 12799517
[No Abstract] [Full Text] [Related]
8. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study.
Syed TA; Goswami J; Ahmadpour OA; Ahmad SA
J Dermatol; 1998 May; 25(5):309-13. PubMed ID: 9640884
[TBL] [Abstract][Full Text] [Related]
9. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
[TBL] [Abstract][Full Text] [Related]
10. An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum.
Metkar A; Pande S; Khopkar U
Indian J Dermatol Venereol Leprol; 2008; 74(6):614-8. PubMed ID: 19171985
[TBL] [Abstract][Full Text] [Related]
11. Interventions for cutaneous molluscum contagiosum.
van der Wouden JC; Menke J; Gajadin S; Koning S; Tasche MJ; van Suijlekom-Smit LW; Berger MY; Butler CC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004767. PubMed ID: 16625612
[TBL] [Abstract][Full Text] [Related]
12. Experience in treating molluscum contagiosum in children with imiquimod 5% cream.
Bayerl C; Feller G; Goerdt S
Br J Dermatol; 2003 Nov; 149 Suppl 66():25-9. PubMed ID: 14616342
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
[TBL] [Abstract][Full Text] [Related]
14. An immunocompromised woman with severe molluscum contagiosum that responded well to topical imiquimod: a case report and literature review.
Lin HY; Linn G; Liu CB; Chen CJ; Yu KJ
J Low Genit Tract Dis; 2010 Apr; 14(2):134-5. PubMed ID: 20354423
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum.
Teixidó C; Díez O; Marsal JR; Giner-Soriano M; Pera H; Martinez M; Galindo-Ortego G; Schoenenberger JA; Real J; Cruz I; Morros R
Pediatr Dermatol; 2018 May; 35(3):336-342. PubMed ID: 29479727
[TBL] [Abstract][Full Text] [Related]
16. Treatment of molluscum contagiosum with imiquimod 5% cream.
Skinner RB
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S221-4. PubMed ID: 12271282
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.
Theos AU; Cummins R; Silverberg NB; Paller AS
Cutis; 2004 Aug; 74(2):134-8, 141-2. PubMed ID: 15379366
[TBL] [Abstract][Full Text] [Related]
18. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
Ross GL; Orchard DC
Australas J Dermatol; 2004 May; 45(2):100-2. PubMed ID: 15068455
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Molluscum Contagiosum with Imiquimod in the United States: A Retrospective Cross-Sectional Study.
Farhangian ME; Huang KE; Feldman SR; Fleischer AB
Pediatr Dermatol; 2016; 33(2):227-8. PubMed ID: 26608213
[TBL] [Abstract][Full Text] [Related]
20. Primary Epibulbar Molluscum Contagiosum in an Immunocompetent Child.
Falzon K; Scotcher S; Parulekar M
J Pediatr; 2015 Oct; 167(4):936. PubMed ID: 26235666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
